COMMONWEALTH OF AUSTRALIA
NATIONAL HEALTH ACT 1953
PHARMACEUTICAL BENEFITS
DECLARATION UNDER SUB-SECTION 85(2AA)

I, JOHN STEWART DEEBLE, Acting First Assistant Secretary, Health Benefits Division, Department of Community Services and Health and Delegate of the Minister of State for Community Services and Health, pursuant to sub-section 85(2AA) of the National Health Act 1953, hereby make the following Declaration:

1.                               This Declaration shall come into operation on 1 April 1988.
2. The drugs and medicinal preparations contained in the Schedule to this Declaration shall cease to be drugs and medicinal preparations to which Part VII of the National Health Act 1953 applies.

THE SCHEDULE

Chloroquine Sulphate Injection B.P.

Chlortetracycline

Chlortetracycline Hydrochloride B.P.

Clorexolone

Ergocalciferol B.P.

Ethanolamine Oleate Injection B.P.

Fluphenazine Hydrochloride B.P.

"Galactomin, Formula No. 17"

Iron Sorbitol Injection B.P.

Liothyronine Tablets B.P.

Magenta B.P.C. 1973

Norgestrel with Ethinyloestradiol B.P.

Oxytetracycline Hydrochloride B.P.

Prednisolone B.P.

Sodium Lactate Intravenous Infusion B.P.

Sulphafurazole Tablets B.P.

Sulphapyridine Tablets B.P.

"Zerodor"

Dated this 30th day of March 1988.

JOHN DEEBLE

ACTING FIRST ASSISTANT SECRETARY

HEALTH BENEFITS DIVISION

DELEGATE OF THE MINISTER OF STATE FOR COMMUNITY SERVICES AND HEALTH